Plus: A startup bioengineering off-the-shelf arteries, how viruses may cause Alzheimer’s, water-powered satellites and more.

(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

Despite millions of cases of norovirus in the U.S. each year—and a current surge in outbreaks—there is still no vaccine for ...

Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...

But one injectable has somehow managed to fly under the radar, evading internet fame and scrutiny, for the better part of a ...

A Phase 1 trial that is testing Modex's vaccine against the Epstein-Barr virus, a strong risk factor for MS, has dosed its ...

Fear of needles is a top reason for vaccine hesitancy and a major obstacle to getting vaccinated for many people around the ...

Professor Jae-Byum Chang and Professor Yeon Sik Jung's joint research team of the Department of Materials Science and ...

Scientists from Duke-NUS Medical School and the Singapore General Hospital have discovered that T cells—white blood cells ...

RNA is the molecule that reads the genetic information stored in DNA. It's critical for the proper functioning of cells, and in a new study published in Nature Communications, University of California ...